Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACSS2 | Q9NR19 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.35 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.35 |
| ▸ | ICMT | O60725 | 4/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.34 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3377295 | 0.89 | EPHX2 (0.40) | ACSS2MAOAMAOBTAAR1DPP4 | |
| SCHEMBL29017350 | 0.87 | ICMT (0.39) | ACSS2MAOAMAOBTAAR1DPP4 | |
| SCHEMBL1561557 | 0.85 | MAOA (0.45) | MAOAMAOBTAAR1DPP4KEAP1 | |
| SCHEMBL15577253 | 0.83 | DPP4 (0.43) | MAOAMAOBTAAR1DPP4CYP2D6 | |
| SCHEMBL1124803 | 0.81 | MAOA (0.56) | MAOAMAOBTAAR1DPP4CYP2D6 | |
| SCHEMBL29017396 | 0.81 | ACSS2 (0.39) | ACSS2MAOAMAOBOPRM1SLC6A4 | |
| SCHEMBL29017399 | 0.81 | SLC6A3 (0.41) | ACSS2MAOAMAOBSLC6A4SLC6A2 | |
| SCHEMBL15577241 | 0.81 | ICMT (0.51) | MAOAMAOBTAAR1DPP4OPRM1 | |
| SCHEMBL29017406 | 0.81 | SLC6A4 (0.41) | ACSS2CYP2D6EPHX2PTGS2SLC6A4 | |
| SCHEMBL16539704 | 0.80 | LTA4H (0.49) | MAOAMAOBEPHX2PTGS2SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116240194-B | Limonene epoxy hydrolase mutant and catalytic synthesis of chiral oxygen/nitrogen-heterocyclic compound thereof | 中国科学院天津工业生物技术研究所 | 2024-11-12 | — | — | CN | claimed |
| CN-116240194-A | Limonene epoxy hydrolase mutant and catalytic synthesis of chiral oxygen/nitrogen-heterocyclic compound thereof | 中国科学院天津工业生物技术研究所 | 2023-06-09 | — | — | CN | claimed |
| EP-4435064-B1 | NONAQUEOUS INKJET INK AND METHOD FOR FORMING CURED PRODUCT | KONICA MINOLTA INC (JP) | 2026-04-22 | — | — | EP | disclosed |
| EP-4721737-A1 | USE OF PHARMACEUTICAL COMPOSITION COMPRISING COMPOUND HAVING BIS(AZANYLYLIDENE) SULFONYL STRUCTURE FOR TREATING ANEMIA-RELATED DISEASES | Scinnohub Pharmaceutical Co., Ltd. (CN) | 2026-04-08 | — | — | EP | disclosed |
| EP-4711426-A1 | ACTIVE RAY-CURABLE INKJET INK COMPOSITION, METHOD FOR FORMING INSULATING FILM, INSULATING FILM, AND PRINTED WIRING BOARD | KONICA MINOLTA, INC. (JP) | 2026-03-18 | — | — | EP | disclosed |
| EP-4603551-A1 | INKJET INK AND METHOD FOR PRODUCING THE SAME, METHOD FOR FORMING CURED PRODUCT, AND METHOD FOR STIRRING INKJET INK | KONICA MINOLTA, INC. (JP) | 2025-08-20 | — | — | EP | disclosed |
| EP-4600317-A1 | INKJET INK, METHODS FOR PRODUCING PIGMENT DISPERSION AND INKJET INK, METHOD FOR FORMING CURED PRODUCT, AND CURED PRODUCT | KONICA MINOLTA, INC. (JP) | 2025-08-13 | — | — | EP | disclosed |
| US-20250145635-A1 | COMPOUND CONTAINING BIS(AZANYLYLIDENE) SULFONYL STRUCTURE AND USE THEREOF IN MEDICINE | SCINNOHUB PHARMACEUTICAL CO., LTD. (CN) | 2025-05-08 | — | — | US | disclosed |
| EP-4534615-A1 | ULTRAVIOLET CURABLE INK, METHOD FOR FORMING CURED PRODUCT, CURED PRODUCT, AND APPARATUS FOR FORMING CURED PRODUCT | KONICA MINOLTA, INC. (JP) | 2025-04-09 | — | — | EP | disclosed |
| EP-4530322-A1 | INKJET INK, METHOD FOR FORMING CURED PRODUCT, AND CURED PRODUCT | KONICA MINOLTA, INC. (JP) | 2025-04-02 | — | — | EP | disclosed |
| CN-119708917-A | Inkjet ink, method for forming cured product, and cured product | 柯尼卡美能达株式会社 | 2025-03-28 | — | — | CN | disclosed |
| EP-1902829-A1 | THREE-DIMENSIONAL SHAPED ITEM WITH SMOOTHED MOLDING END FACE | Cmet Inc. (JP) | 2008-03-26 | — | — | EP | disclosed |
| US-20070060682-A1 | Actinic radiation-curable stereolithographic resin composition having improved stability | CMET INC. (JP) | 2007-03-15 | — | — | US | disclosed |
| EP-1693427-A2 | Ink for inkjet printing, lithographic printing plate using it and method for making such plate | FUJI PHOTO FILM CO., LTD. (JP) | 2006-08-23 | — | — | EP | disclosed |
| US-20060181591-A1 | Ink for inkjet printing, lithographic printing plate using it and method for making such plate | FUJI PHOTO FILM CO., LTD. | 2006-08-17 | — | — | US | disclosed |
| US-20060141276-A1 | Three-dimensional structure and method for production thereof | CMET INC. (JP) | 2006-06-29 | — | — | US | disclosed |
| US-7048368-B2 | Ink-jet image forming method | KONICA CORPORATION (JP) | 2006-05-23 | — | — | US | disclosed |
| US-7014310-B2 | Inkjet image forming method and inkjet image forming system | KONICA CORPORATION (JP) | 2006-03-21 | — | — | US | disclosed |
| US-20040036753-A1 | Ink-jet image forming method | KONICA CORPORATION (JP) | 2004-02-26 | — | — | US | disclosed |
| US-20030202079-A1 | Inkjet image forming method and inkjet image forming system | KONICA CORPORATION (JP) | 2003-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250145635-A1 | COMPOUND CONTAINING BIS(AZANYLYLIDENE) SULFONYL STRUCTURE AND USE THEREOF IN MEDICINE | BCL9, USP9X, BCL9L | ACSS2 1969/4885MAOA 4216/4885MAOB 4311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.